Newsig · CNBC
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
Why it matters
WMT (Walmart) · Why linked: Walmart is the employer expanding its benefits to include GLP-1s, inhalers, and insulin at no cost. Market context: Expanded employee health coverage increases Walmart's near-term benefits costs but supports worker health and productivity.
LLY (Eli Lilly) · Why linked: Eli Lilly makes Mounjaro, another GLP-1 drug Walmart will now cover for employees with Type 2 diabetes. Market context: Inclusion of Mounjaro in Walmart's expanded coverage supports prescription adoption and revenue growth.
Reaction tracking
A completed 24-hour reaction record is not available for this story yet. Newsig only publishes measured price movement when the required market data is present.
Curated by Newsig — News in. Signal out.
How the reaction data is measured · Editorial policy